Remission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy.

Tai, Cheng-Jeng

Remission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy. [electronic resource] - Gynecologic oncology Apr 2006 - 184-5 p. digital

Publication Type: Case Reports; Letter

0090-8258

10.1016/j.ygyno.2005.11.043 doi


Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Female
Humans
Neoplasm Metastasis
Ovarian Neoplasms--metabolism
Receptor, ErbB-2--biosynthesis
Salvage Therapy
Trastuzumab